These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33390033)

  • 1. Communicating Scientific Uncertainty in an Age of COVID-19: An Investigation into the Use of Preprints by Digital Media Outlets.
    Fleerackers A; Riedlinger M; Moorhead L; Ahmed R; Alperin JP
    Health Commun; 2022 May; 37(6):726-738. PubMed ID: 33390033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reporting preprints in the media during the COVID-19 pandemic.
    van Schalkwyk F; Dudek J
    Public Underst Sci; 2022 Jul; 31(5):608-616. PubMed ID: 35196912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Science in motion: A qualitative analysis of journalists' use and perception of preprints.
    Fleerackers A; Moorhead LL; Maggio LA; Fagan K; Alperin JP
    PLoS One; 2022; 17(11):e0277769. PubMed ID: 36409723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Communicating scientific uncertainty in a rapidly evolving situation: a framing analysis of Canadian coverage in early days of COVID-19.
    Capurro G; Jardine CG; Tustin J; Driedger M
    BMC Public Health; 2021 Nov; 21(1):2181. PubMed ID: 34844582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in health communication in the age of COVID-19: A study on the dissemination of preprints to the public.
    Zeng L
    Front Public Health; 2023; 11():1078115. PubMed ID: 36844813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscape.
    Fraser N; Brierley L; Dey G; Polka JK; Pálfy M; Nanni F; Coates JA
    PLoS Biol; 2021 Apr; 19(4):e3000959. PubMed ID: 33798194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Framing COVID-19 Preprint Research as Uncertain: A Mixed-Method Study of Public Reactions.
    Ratcliff CL; Fleerackers A; Wicke R; Harvill B; King AJ; Jensen JD
    Health Commun; 2024 Apr; 39(2):283-296. PubMed ID: 36683347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of citations of medRxiv preprints in articles published on COVID-19 in the world leading medical journals.
    Gehanno JF; Grosjean J; Darmoni SJ; Rollin L
    PLoS One; 2022; 17(8):e0264661. PubMed ID: 35947594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in evidence for studies assessing interventions for COVID-19 reported in preprints: meta-research study.
    Oikonomidi T; Boutron I; Pierre O; Cabanac G; Ravaud P;
    BMC Med; 2020 Dec; 18(1):402. PubMed ID: 33334338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Publication and Impact of Preprints Included in the First 100 Editions of the CDC COVID-19 Science Update: Content Analysis.
    Otridge J; Ogden CL; Bernstein KT; Knuth M; Fishman J; Brooks JT
    JMIR Public Health Surveill; 2022 Jul; 8(7):e35276. PubMed ID: 35544426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the Impact of Communicating Uncertainty About COVID-19 in the News: Randomized Between-Subjects Factorial Experiment.
    Zhao R; Lu X; Yang J; Li B
    J Med Internet Res; 2024 May; 26():e51910. PubMed ID: 38743940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting COVID-19 preprints: fast science in newspapers in the United States, the United Kingdom and Brazil.
    Massarani L; Neves LFF
    Cien Saude Colet; 2022 Mar; 27(3):957-968. PubMed ID: 35293473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Counterpoint: Preprints and the Future of Scientific Publishing-In Favor of Relevance.
    Glymour MM; Charpignon ML; Chen YH; Kiang MV
    Am J Epidemiol; 2023 Jul; 192(7):1043-1046. PubMed ID: 36958814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Asymmetric Influence of Emotion in the Sharing of COVID-19 Science on Social Media: Observational Study.
    Luo K; Yang Y; Teo HH
    JMIR Infodemiology; 2022; 2(2):e37331. PubMed ID: 36536762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Publication rate and citation counts for preprints released during the COVID-19 pandemic: the good, the bad and the ugly.
    Añazco D; Nicolalde B; Espinosa I; Camacho J; Mushtaq M; Gimenez J; Teran E
    PeerJ; 2021; 9():e10927. PubMed ID: 33717688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Communicating Scientific Uncertainty About the COVID-19 Pandemic: Online Experimental Study of an Uncertainty-Normalizing Strategy.
    Han PKJ; Scharnetzki E; Scherer AM; Thorpe A; Lary C; Waterston LB; Fagerlin A; Dieckmann NF
    J Med Internet Res; 2021 Apr; 23(4):e27832. PubMed ID: 33769947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical industry-authored preprints: scientific and social media impact.
    Subramanian K; Nalli A; Senthil V; Bhat A
    Curr Med Res Opin; 2021 Feb; 37(2):269-273. PubMed ID: 33206000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Introduction to the quality of medical journalism and initial assessments of COVID-19 media coverage].
    Daube D; Ruhrmann G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Jan; 64(1):3-11. PubMed ID: 33252701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Clinical Study Results Reported in medRxiv Preprints vs Peer-reviewed Journal Articles.
    Janda G; Khetpal V; Shi X; Ross JS; Wallach JD
    JAMA Netw Open; 2022 Dec; 5(12):e2245847. PubMed ID: 36484989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making science public: a review of journalists' use of Open Access research.
    Fleerackers A; Chtena N; Pinfield S; Alperin JP; Barata G; Oliveira M; Peters I
    F1000Res; 2023; 12():512. PubMed ID: 37920454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.